Jan 13, 2020 / 10:30PM GMT
Eric William Joseph - JP Morgan Chase & Co, Research Division - VP & Senior Analyst
Okay. Great. We're going to get started here. Good afternoon. I'm Eric Joseph, one of the senior biotech analysts at JPMorgan. And our next presenting company this afternoon is Enanta Pharmaceuticals. It's my pleasure to welcome to speak to us about the company, CEO, Jay Luly. Before I -- Jay comes to the podium, I just want to remind folks in the room that the breakout session for this presentation will be in the Sussex room.
With that, Jay?
Jay R. Luly - Enanta Pharmaceuticals, Inc. - President, CEO & Director
Thank you very much, Eric, and thank you for the opportunity to speak to you today. Before I begin, I want to remind you, I'll be making some forward-looking statements. For a summary of the risks associated with these statements, please see our filings on sec.gov and on our website.
So for those of you who may not be totally familiar with Enanta, we are a virology and liver-focused biotech company. We have multiple stages in multiple
Enanta Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers